CAS NO: | 870823-12-4 |
生物活性 | MK 0893 is a potent and selectiveglucagon receptorantagonist with anIC50of 6.6 nM. | ||||||||||||||||
IC50& Target | IC50: 6.6 nM (glucagon receptor) | ||||||||||||||||
体外研究 (In Vitro) | MK 0893 is selective for glucagon receptor relative to other family B GPCRs, showing IC50values of 1020 nM for GIPR, 9200 nM for PAC1, and >10000 nM for GLP-1R, VPAC1, and VPAC2. MK 0893 is active against the rhesus monkey GCGR, showing an IC50of 56 nM in a cAMP assay with CHO cells expressing the rhesus GCGR[1]. | ||||||||||||||||
体内研究 (In Vivo) | MK 0893 blunts glucagon-induced glucose elevation in hGCGR mice and rhesus monkeys. It also lowers ambient glucose levels in both acute and chronic mouse models: in hGCGR ob/ob mice it reduces glucose (AUC 0-6 h) by 32% and 39% at 3 and 10 mpk single doses, respectively. In hGCGR mice on a high fat diet, MK 0893 at 3, and 10 mpk po in feed lowers blood glucose levels by 89% and 94% at day 10, respectively, relative to the difference between the vehicle control and lean hGCGR mice[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 588.48 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C32H27Cl2N3O4 | ||||||||||||||||
CAS 号 | 870823-12-4 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 33.33 mg/mL(56.64 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在本网站选购。 |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |